planosporicin: isolated from Planomonospora; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Planosporicin is a ribosomally synthesized, posttranslationally modified peptide lantibiotic produced by the actinomycete Planomonospora alba. It is a 2194 Da polypeptide originating from 24 proteinogenic amino acids.
| Excerpt | Reference |
|---|---|
| "Planosporicin is a type AI lantibiotic structurally similar to those which bind lipid II, the immediate precursor for cell wall biosynthesis." | ( Cloning and analysis of the planosporicin lantibiotic biosynthetic gene cluster of Planomonospora alba. Bibb, MJ; Hesketh, AR; Sherwood, EJ, 2013) |
| "Planosporicin is a ribosomally synthesized, posttranslationally modified peptide lantibiotic produced by the actinomycete Planomonospora alba. " | ( The antibiotic planosporicin coordinates its own production in the actinomycete Planomonospora alba. Bibb, MJ; Sherwood, EJ, 2013) |
| "Planosporicin is a 2194 Da polypeptide originating from 24 proteinogenic amino acids." | ( A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Candiani, G; Carrano, L; Castiglione, F; Cavaletti, L; Ciciliato, I; Corti, E; Feroggio, M; Lazzarini, A; Losi, D; Marinelli, F; Selva, E, 2007) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||